Jazz Pharmaceuticals JAZZ Europe — Revenue from Contract with Customer, Excluding Assessed Tax

Other geography segments

Similar metrics at other companies

KEYSEurope — Revenue from Contract with Customer, Excluding Assessed Tax

$328M+47.1%

AMRCEurope — Revenue from Contract with Customer, Excluding Assessed Tax

$127.43M+31.8%

ATRCEurope — Revenue from Contract with Customer, Excluding Assessed Tax

$17.21M+6.7%

MTDEurope — Revenue from Contract with Customer, Excluding Assessed Tax

$278.69M+12.4%

ATREurope — Revenue from Contract with Customer, Excluding Assessed Tax

$465.64M+5.2%

BCEurope — Revenue from Contract with Customer, Excluding Assessed Tax

$243.9M+7.8%

FAQ

What is Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax?

Jazz Pharmaceuticals (JAZZ) reported europe — revenue from contract with customer, excluding assessed tax of $92.4M in Q1 2026.

How has Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax changed year-over-year?

Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax increased by 10.5% year-over-year, from $83.6M to $92.4M.

What is the long-term trend for Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's europe — revenue from contract with customer, excluding assessed tax has grown at a 10.3% compound annual growth rate (CAGR), from $230.85M to $341.68M.

What does europe — revenue from contract with customer, excluding assessed tax mean?

This metric represents the total net revenue generated from the sale of pharmaceutical products and services within the European geographic segment, net of any applicable sales taxes. It reflects the commercial success and market penetration of the company's neuroscience and oncology portfolio in this specific region. This figure is a key indicator of the company's international growth trajectory and its ability to navigate diverse regulatory and reimbursement environments across European markets.